Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 10.14
+0.16 (1.60%)
At close: May 8, 2026
SHE:301301 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 591.52 | 769.01 | 1,400 | 940.56 | 411.52 | 111.35 |
Depreciation & Amortization | 587.5 | 587.5 | 558.47 | 550.11 | 547.73 | 524.05 |
Other Amortization | 0.88 | 0.88 | 0.88 | 0.99 | 1.32 | 0.66 |
Loss (Gain) From Sale of Assets | -0.35 | -0.35 | - | -1.34 | - | -0.26 |
Asset Writedown & Restructuring Costs | 1.39 | 1.39 | 1.25 | 1.28 | 31.55 | 16.82 |
Loss (Gain) From Sale of Investments | 3.55 | 3.55 | -0.36 | 4.57 | 3.7 | -3.89 |
Provision & Write-off of Bad Debts | 3.69 | 3.69 | -6.69 | 6.5 | - | - |
Other Operating Activities | 307.45 | 63.86 | 72.44 | 127.13 | 138.23 | 167.77 |
Change in Accounts Receivable | -527.48 | -527.48 | -557.51 | -274.69 | -424.19 | 78.13 |
Change in Inventory | -182.29 | -182.29 | 317.3 | -335.46 | 53.31 | -7.75 |
Change in Accounts Payable | -162.49 | -162.49 | -7.99 | 264.92 | -63.77 | -80.07 |
Change in Other Net Operating Assets | -7.3 | -7.3 | 12.49 | 17.9 | -3.46 | -0.66 |
Operating Cash Flow | 615.16 | 549.06 | 1,791 | 1,292 | 691.64 | 803.21 |
Operating Cash Flow Growth | -62.42% | -69.34% | 38.59% | 86.86% | -13.89% | 23.61% |
Capital Expenditures | -104.04 | -97.21 | -42.6 | -345.13 | -47.2 | -52.27 |
Sale of Property, Plant & Equipment | 0 | 0 | 0.05 | 0.02 | - | 0.77 |
Investment in Securities | 25.17 | -134.72 | -64.29 | - | -7 | 3.34 |
Other Investing Activities | -0.01 | - | 0.63 | -8.27 | - | - |
Investing Cash Flow | -78.88 | -231.93 | -106.22 | -353.37 | -54.2 | -48.16 |
Long-Term Debt Issued | - | 747.99 | 780 | 851.8 | 1,164 | 932.93 |
Long-Term Debt Repaid | - | -818.94 | -1,622 | -2,369 | -1,582 | -1,514 |
Net Debt Issued (Repaid) | -194.61 | -70.95 | -842.19 | -1,517 | -417.97 | -581.5 |
Issuance of Common Stock | 12.94 | 12.94 | 20.26 | - | 1,050 | - |
Common Dividends Paid | -621.62 | -622.1 | -545.07 | -290.12 | -142.82 | -167.8 |
Other Financing Activities | -20.68 | 6.2 | 5.93 | -1.07 | -13.42 | - |
Financing Cash Flow | -823.98 | -673.92 | -1,361 | -1,808 | 475.92 | -749.29 |
Foreign Exchange Rate Adjustments | -4.34 | 2.67 | 6.54 | 3.33 | 4.1 | -6.51 |
Net Cash Flow | -292.05 | -354.12 | 330.32 | -866.11 | 1,117 | -0.76 |
Free Cash Flow | 511.11 | 451.85 | 1,748 | 947.26 | 644.44 | 750.94 |
Free Cash Flow Growth | -68.82% | -74.16% | 84.58% | 46.99% | -14.18% | 33.96% |
Free Cash Flow Margin | 11.58% | 9.79% | 30.36% | 19.64% | 16.87% | 23.23% |
Free Cash Flow Per Share | 0.23 | 0.20 | 0.79 | 0.42 | 0.33 | 0.41 |
Cash Income Tax Paid | 433 | 517.11 | 648.47 | 529.02 | 283.66 | 134.55 |
Levered Free Cash Flow | 532.05 | 569.43 | 1,681 | 855.08 | 538.48 | 712.11 |
Unlevered Free Cash Flow | 552 | 590.57 | 1,719 | 909.94 | 627.44 | 822.66 |
Change in Working Capital | -880.47 | -880.47 | -235.25 | -337.42 | -442.41 | -13.29 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.